Bharat Immunologicals (India) Valuation Overview

BIBCL -- India Stock  

INR 20.40  1.55  8.22%

Bharat Immunologicals shows prevailing Real Value of 20.525000249999998 per share. The current price of the firm is 20.4. At this time the firm appears to be fairly valued. Macroaxis approximates value of Bharat Immunologicals from analyzing the firm fundamentals such as Operating Margin of 4.32% and Return On Asset of (1.69)% as well as examining its technical indicators and Probability Of Bankruptcy. In general, we favor to go long with undervalued instruments and to trade away overvalued instruments since at some point assets prices and their ongoing real values will blend.
 Time Horizon     30 Days    Login   to change
Bharat Immunologicals Biologicals Corp Ltd is rated below average in price to sales category among related companies. It is number one stock in price to earning category among related companies reporting about  261.65  of Price to Earning per Price to Sales.

Current Market Valuation

Bharat Immunologicals Valuation Boundaries
Fairly Valued
May 22, 2018
20.40
Market Value
20.53
Real Value
Target Odds
  
27.28
Upside
Bharat Immunologicals is not very risky asset. Calculation of real value of Bharat Immunologicals is based on 1 month time horizon. Increasing Bharat Immunologicals time horizon generally increases accuracy of value calculation and significantly improves predictive power of the methodology used.
Check also Trending Equities. Please also try Equity Analysis module to research over 250,000 global equities including funds, stocks and etfs to find investment opportunities.